Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Dec
15
2016
U.S. Supreme Court Grants Certiorari to Review Patent Venue Statute Foley & Lardner LLP
Oct
7
2020
Federal Circuit Orders Partial Dismissal of Voip-Pal’s IPR Challenged Claims Foley & Lardner LLP
Jan
7
2021
In Support of Arthrex – Amicus Briefs Urge Court To Leave Remedy To Congress Foley & Lardner LLP
Jan
20
2021
The Indefinite Peril Of Claim Drafting Foley & Lardner LLP
Jun
20
2017
Cleveland Clinic Decision Highlights Catch-22 Of Personalized Medicine Patents Foley & Lardner LLP
Apr
3
2015
Do You Really Own All Your Intellectual Property? Foley & Lardner LLP
Apr
24
2015
Win or Lose, Trademark Applicants Must Pay PTO Attorney Fees in Appeals to District Court, Fourth Circuit Says Foley & Lardner LLP
Mar
17
2022
PTAB Precedential Decision Clarifies When a Wire Transfer “Payment Is Received” by the Board Foley & Lardner LLP
May
19
2015
The Importance of Contracts for Joint Infringement in Patent Cases Foley & Lardner LLP
May
27
2015
Dependent Claims Give Rise To Improper Broadening Reissue re: Patent Applications Foley & Lardner LLP
Dec
19
2017
Federal Circuit Finds Preemption Of State Law Penalty For Sitting Out Biosimilar Patent Dance Foley & Lardner LLP
Jul
19
2022
USPTO Proposes To Require Form For IDS PTA Safe Harbor Foley & Lardner LLP
Feb
16
2018
Federal Circuit: Pre-IPR Institution Disclaimer of Claims Insufficient to Avoid Adverse Judgment Foley & Lardner LLP
Oct
3
2022
UPSTO Extends Pilot Programs Foley & Lardner LLP
Oct
28
2022
2022 NFT Litigation Roundup Foley & Lardner LLP
Aug
24
2015
Delaware Judges Are Finding Patent Claims Indefinite Post-Nautilus Foley & Lardner LLP
Sep
8
2015
Patent Trial and Appeal Board Boots Bass Tecfidera IPR On The Merits Foley & Lardner LLP
Jun
22
2018
Supreme Court Allows Foreign Lost Profits on Domestic Acts of Patent Infringement Under 35 U.S.C. § 271(f)(2) Foley & Lardner LLP
Jul
1
2018
We all Scream for . . . Ice Cream Patents Foley & Lardner LLP
Oct
19
2015
No Rehearing Of Biosimilar Patent Dance Decision Foley & Lardner LLP
Oct
10
2018
PTAB Aligns Its Claim Construction Standard to Phillips, Replacing BRI Foley & Lardner LLP
Dec
19
2018
When a Promise Isn’t Enough – Crafting Proper Employee Patent Assignments Foley & Lardner LLP
Jan
7
2019
USPTO Releases 2019 Eligibility Update Foley & Lardner LLP
Jan
28
2019
Supreme Court Finds The On Sale Bar Is The Same As It Ever Was Foley & Lardner LLP
Dec
17
2015
Australian Patent Office Provides Patent Eligibility Guidance Foley & Lardner LLP
Feb
19
2019
Termination Of Product Development Precludes Standing To Appeal PTAB IPR Decision Upholding Patent Foley & Lardner LLP
Aug
23
2023
Nothing for Free: Federal Circuit Clarifies Commercial Success is All About Sales Foley & Lardner LLP
Jan
10
2016
Federal Circuit Orders IPR Remand On Board's Treatment Of Evidence Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins